Examinando por Autor "Buitron Arenaza, Rossillo Vanessa"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    PublicaciónAcceso abierto
    Problemas relacionados a las nuevas moléculas en pacientes ambulatorios con diabetes mellitus tipo 2, según la clasificación del Segundo Consenso de Granada en la Clínica Internacional; enero 2015–marzo 2017
    (Universidad Privada Norbert Wiener, 2019-01-31) Chávez Taype, Katherine; Buitron Arenaza, Rossillo Vanessa; Caldas Herrera, Emma
    The objective of this study was to identify drug-related problems (DRPs) associated with new molecules in outpatients with type 2 diabetes mellitus, according to the classification of the Second Granada Consensus, at Clínica Internacional between January 2015 and March 2017. A descriptive, retrospective, and longitudinal study was conducted, with a population of 359 patients and a sample of 172 patients over 35 years of age. Clinical records were reviewed, with emphasis on those receiving treatment with new molecules (Kombiglyze, Onglyza, Trayenta, Toujeo, Jardiance, Victoza, Forxiga, Tresiba), prescribed by the Endocrinology Department. A DRP Identification Form was used to achieve the study objectives. Through pharmacotherapeutic follow-up, a total of 441 DRPs were identified, of which 58.7% (259) corresponded to male patients and 41.3% (182) to female patients. Potential DRPs accounted for 68.9% (304) and actual DRPs for 31.1% (137). Regarding the subtypes of DRPs, those related to necessity (DRP1) represented 15% (66), those related to effectiveness (DRP3) accounted for 5% (22), those related to safety (DRP5) represented 78% (346), and DRP6 accounted for 2% (7).